Posts

Showing posts from January, 2022

Weight Loss and Weight Management Market worth $303.81 billion by 2027

According to a new market research report Weight Loss and Weight Management Market by Equipment (Fitness (Treadmill, Elliptical, Stair Stepper), Surgical Equipment (Biliopancreatic Diversion, Gastric Bypass)), Diet (Meal, Beverage, Supplement), and Weight Loss Services - Global Forecast to 2027, published by MarketsandMarkets™, the market is estimated to reach USD 303.81 billion by 2027 from USD 175.94 billion in 2017, at a CAGR of 6.9%. Browse 143 Market Data Tables and 33 Figures spread through 187 Pages and in-depth TOC on "Weight Loss Obesity Management Market" Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=1152 Beverages segment to dominate the market in 2017 Based on diet, the weight loss and weight management market is segmented into meals, beverages, and supplements. In 2017, the beverages segment is expected to account for the largest share of the weight loss management market. Growth in this segment is majorly driven by the

In Vitro Toxicity Testing Market is expected to reach $14.9 billion by 2025

 According to the new market research report In Vitro Toxicity Testing Market is expected to reach USD 14.9 billion by 2025 from an estimated USD 9.1 billion in 2020, at a CAGR of 10.3%. Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=209577065 Due to covid-19 outbreak, there has been a significant increase in Covid-19 testing and drug research. The research in this area is being further undertaken to understand the dynamics of the infection better, which is expected to propel the in vitro toxicology research field further. On the other hand, we are estimating that the major share of diagnostic assays and molecular testing of Covid-19, along with personalized medicine will grow at a stable pace in the next five years. There is a huge increase of manufacturers that have taken key steps to increase patient access to coronavirus diagnostic testing, vaccine and drug development in laboratories, hospitals, and other testing sites across the count

Medical Wearables Market Worth $19.5 Billion by 2025

   According to the new market research report Medical Wearables Market by Device (Vital Signs Monitoring, Blood Pressure Monitor, Glucose Monitor, ECG Monitor, Pulse Oximeter), Product (Smartwatch, Patches, Wristbands), End User (Hospitals, Nursing Homes, Ambulatory) - Global Forecast to 2025, published by MarketsandMarkets™, the Medical Wearables Market size is projected to reach USD 19.5 billion by 2025 from USD 7.4 billion in 2020, at a CAGR of 21.4 % during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=52426876 The growing adoption of smartphones, increasing penetration of 3G/4G networks, growing geriatric population, and rising focus on cost containment in healthcare delivery are driving the greater uptake of mobile technologies. The vital sign monitoring device segment accounted for the largest share of the Clinical-Grade Wearable market in 2019 Based on device type, the vital sign monitoring segment accounted fo

Hyperspectral Imaging Systems Market worth $42.96 bill by 2027

According to research report the global hyperspectral imaging systems market is projected to reach USD 42.96 billion by 2027 from USD 9.51 billion in 2018, at a CAGR of 17.5%. The growing industrial applications of hyperspectral imaging and increasing funding & investments are the major factors driving the growth of the global hyperspectral imaging systems market. Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=246979343 by product, the cameras segment is expected to dominate the market in 2018 The hyperspectral imaging systems market is categorized into two product segments, namely, cameras and accessories. The cameras segment is expected to command the largest share of the global hyperspectral imaging systems market in 2018. Factors such as recent advances in sensor development & computing power and the availability of low-cost cameras with widening industrial applications are driving the growth of this market segment. Based on appl

Clinical Microbiology Market – Key Players and Business Strategies

According to research report the global clinical microbiology market is projected to reach $4.9 billion by 2023, at a CAGR of 6.4% from 2018 to 2023. Growth in the clinical microbiology market can be attributed to the technological advancements in the disease diagnostics, rising incidence of infectious diseases and growing outbreak of epidemics, and increased funding and public-private investments in the field of disease diagnosis. On the other hand, reimbursement concerns and unfavorable regulatory scenario are expected to limit market growth to a certain extent. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=219135367 The major players operating in the clinical microbiology market include bioMérieux SA (France), Danaher Corporation (US), Becton, Dickinson and Company (US), Abbott Laboratories Inc. (US), Bio-Rad Laboratories Inc. (US), F. Hoffmann La-Roche Ltd. (Switzerland), Bruker Corporation (US), and Hologic Inc. (US) among others. An a

Cancer Immunotherapy Market Worth 119.39 Billion USD by 2021

According to a new market research " Cancer Immunotherapy Market by Type (Monoclonal Antibodies, Cancer Vaccines, Check Point Inhibitors & Immunomodulators), Application (Lung, Breast, Colorectal, Melanoma, Prostate, Head & Neck), End User (Hospital and Clinics) - Global Forecast to 2021", published by MarketsandMarkets, the global Cancer Immunotherapy Market is expected to reach USD 119.39 Billion by 2021 from USD 61.9 Billion in 2016, at a CAGR of 14.0% from 2016 to 2021. Factors such as increasing incidence of cancer and rising healthcare expenditure are driving the growth of this market. Browse 43 market data Tables and 69 Figures spread through 145 Pages and in-depth TOC on "Cancer Immunotherapy Market" Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=197577894 In this report, the global Cancer Immunotherapy Market has been segmented based on type, application, end user, and region. On the basis of type, the ma

IVD Quality Control Market Development - Industry Report 2025

According to research report the global In Vitro Diagnostics Quality Control Market is projected to reach USD 1,158 million by 2025 from USD 961 million in 2020, at a CAGR of 3.8% during the forecast period. The market for IVD quality control is primarily driven by increasing demands for laboratory accreditation, as well as the rising number of accredited laboratories and growing adoption of third-party quality controls. However, the lack of regulations for clinical laboratory accreditation in several emerging countries will challenge market growth. Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=198032582 Based on product and service, the IVD quality control market is segmented into quality control products, data management solutions, and quality assurance services. In 2019, quality control products accounted for the largest share of the global IVD quality control market. Growth in the quality control products market can be attributed to th

Genome Editing Market worth $11.2 billion by 2025

  According to the new market research report " Genome Editing Market by Technology (CRISPR, TALEN, ZFN, Antisense), Product & Service, Application (Cell Line Engineering, Genetic Engineering, Diagnostics, Drug Discovery & Development), End-User and Region - Global Forecast to 2025", published by MarketsandMarkets™, the global Genome Engineering Market is projected to reach USD 11.2 billion in 2025 from USD 5.1 billion in 2020, at a CAGR of 17.0 % during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=231037000 The market growth is largely driven by factors such as the rise in government funding, growth in the number of genomics projects, high prevalence of infectious diseases and cancer, technological advancements, increasing production of genetically modified crops, and growing application areas of genomics. However, the high cost of genomic equipment will restrain the growth of this market. By techno

dPCR and qPCR Market – Growth Strategy Adopted Top Market Players - Industry Report 2024

According to research report the digital PCR market is projected to reach USD 6.3 billion by 2024 from USD 4.1 billion in 2019, at a CAGR of 8.8% from 2019 to 2024. The rising incidences of infectious diseases (such as HIV, tuberculosis, and malaria) and genetic disorders; continuous technological advancements in PCR technologies and the commercialization of lab-on-chip devices and microfluidics-based portable instruments; increasing investments, funds, and grants for genomic research; increasing use of biomarker profiling for disease diagnostics; and the successful completion of the Human Genome Project are expected to augment the growth of the global Digital PCR Market over the forecast period. On the other hand, the high instrument costs—especially that of dPCR—and the technical limitations of PCR are expected to limit market growth to a certain extent. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174151204 The major players operating

Hyperspectral Imaging Systems Market worth $30.0 billion by 2025

According to the new market research report Hyperspectral Imaging Systems Market by Product (Camera, Accessories), Technology (Snapshot, Push broom), Application (Military, Remote Sensing (Agriculture, Mining, Environmental), Machine Vision, Life Sciences & Medical Diagnosis) - Global Forecast to 2025, published by MarketsandMarkets™, the Hyperspectral Imaging System Market is projected to reach USD 30.0 billion by 2025 from USD 12.4 billion in 2020, at a CAGR of 19.3%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=246979343 The growing industrial applications of hyperspectral imaging and increasing funding and investments are the major factors driving the growth of this market. In 2019, the cameras segment accounted for the largest share of the market On the basis of product, the Hyperspectral Imaging Systems Market is segmented into cameras and accessories. Cameras are expected to command the larger share of the market, by product, i

AI in Genomics Market worth USD 1,671 million by 2025

According to the new market research report AI in Genomics Market is projected to reach USD 1,671 million by 2025 from USD 202 million in 2020, at a CAGR of 52.7% between 2020 and 2025 Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=36649899 The need to control drug development and discovery costs and time, increasing public and private investments in AI in genomics, and the adoption of AI solutions in precision medicine are driving the growth of this market. However, the lack of a skilled AI workforce and ambiguous regulatory guidelines for medical software are expected to restrain the market growth during the forecast period. Based on functionality, the Artificial Intelligence in Genomics Market is segmented into genome sequencing, gene editing, clinical workflows, and predictive genetic testing & preventive medicine. Genome sequencing was the largest functionality segment in this market in 2019 and is estimated to grow at highest CAGR i

Defibrillators Market Worth $11.7 Billion by 2025

According to the new market research report Defibrillators Market by Product [Implantable Cardioverter Defibrillator (Transvenous ICD, Single & Dual Chamber, CRT-D, S-ICD), External (Manual, AED, Wearable)], End User (Hospitals, Pre-hospital, Public Access, Home care) - Global Forecast to 2025, published by MarketsandMarkets™, the Defibrillators Market is projected to reach USD 11.7 billion by 2025 from USD 9.6 billion in 2019, growing at a CAGR of 3.4% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=549 The growth in this market is driven by the rising prevalence of target diseases, growing focus on providing public-access defibrillators, and training and awareness programs on defibrillators. In addition, emerging markets and the development of S-ICDs and MRI-compatible ICDs and CRT-Ds are expected to offer growth opportunities for players in the market. However, issues related to the use of implantable a

Spatial Genomics Market worth $404 mill by 2025

According to the new market research report the global spatial genomics market is projected to reach USD 404 million by 2025 from USD 178 million in 2020, at a CAGR of 17.8% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170900551 The major factors driving the growth of the spatial genomics and transcriptomics market are the increasing adoption of spatial genomics and transcriptomics techniques for drug discovery & development and the increasing R&D investments and public-private funding. Additionally, the introduction of technologically advanced instruments for spatial genomics analysis is also boosting the market growth. However, the high capital investments associated with spatial genomics and transcriptomics are a major factor restraining market growth. Spatial genomics & transcriptomics market is categorized into major four product categories, techniques, product, application and end user. Among th

Weight Loss and Weight Management Market Worth $245.51 Billion by 2022 - Exclusive Report by Markets

According to the new market research report Weight Loss and Weight Management Market by Equipment (Fitness (Treadmill, Elliptical, Stair Stepper), Surgical Equipment (Biliopancreatic Diversion, Gastric Bypass)), Diet (Meal, Beverage, Supplement), and Weight Loss Services - Global Forecast to 2022, published by MarketsandMarkets™, the Weight Loss And Weight Management Market is expected to reach USD 245.51 billion by 2022 from USD 175.94 billion in 2017, at a CAGR of 6.9%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1152 The prevalence of childhood obesity is increasing across the globe owing to factors such as the lack of physical activity and unhealthy eating habits. Overweight or obese children are more likely to be obese in their adulthood and are more prone to suffer from diabetes and CVD at an early age. In 2014, globally, the number of overweight children (under the age of 5) was estimated to be over 41 million (Source: World H

MIS Instruments Market worth $32.7 billion by 2025

According to research report MIS Instruments Market is expected to grow from USD 20.1 billion in 2019 to USD 32.7 billion by 2025, at a CAGR of 8.5%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=682 The advantages of minimally invasive surgeries over traditional open surgeries and the increasing number of minimally invasive surgical procedures across the globe are the key factors driving market growth. The major companies in the global MIS instruments market include Medtronic plc (Ireland), Johnson & Johnson (US), Stryker Corporation (US), B. Braun Melsungen AG (Germany), Smith & Nephew plc (US), Boston Scientific Corporation (US), and CONMED Corporation (US). Handheld instruments accounted for the largest share of the global MIS instruments market in 2018. Based on product, the MIS instruments market is segmented into handheld instruments, inflation devices, surgical scopes, cutting instruments, guiding devices, electrosurgical &

Medical Wearables Market Worth $19.5 Billion by 2025 - Exclusive Report by MarketsandMarkets™

According to the new market research report Medical Wearables Market by Device (Vital Signs Monitoring, Blood Pressure Monitor, Glucose Monitor, ECG Monitor, Pulse Oximeter), Product (Smartwatch, Patches, Wristbands), End User (Hospitals, Nursing Homes, Ambulatory) - Global Forecast to 2025, published by MarketsandMarkets™, the Medical Wearables Market size is projected to reach USD 19.5 billion by 2025 from USD 7.4 billion in 2020, at a CAGR of 21.4 % during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=52426876 The growing adoption of smartphones, increasing penetration of 3G/4G networks, growing geriatric population, and rising focus on cost containment in healthcare delivery are driving the greater uptake of mobile technologies. The vital sign monitoring device segment accounted for the largest share of the Clinical-Grade Wearable market in 2019 Based on device type, the vital sign monitoring segment accounte

Oral Care Market – Latest Trends and Future Development - Analysis Report 2025

According to research report the global oral care market is expected to reach USD 53.3 billion by 2025 from USD 44.5 billion in 2019, at a CAGR of 3.0%. Factors such as the rise in the prevalence of dental diseases and the growing awareness about oral healthcare are expected to drive the growth of the market. Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=80546246 In recent years, product innovation has enabled the development of technologically advanced and easy-to-use oral care products, such as electric, artificial intelligence-equipped (AI), and vibrating toothbrushes. Major players have also launched interactive toothbrushes equipped with position detection and motion sensor technologies. These toothbrushes screen the oral cavity to provide real-time guidance for brushing and maintaining oral health. Electronic toothbrushes have witnessed growing adoption across both developed and developing countries, such as Brazil, Italy, the US,

Liquid Biopsy Market Worth 2.04 Million USD by 2022

According to a new market research report Liquid Biopsy Market by Cancer Type (Lung, Breast, Colorectal, Prostate), Circulating Biomarkers (Circulating Tumor Cells, Circulating Tumor DNA, Cell-Free DNA), Product (Instruments, Assay Kits), End User (Reference Laboratory) - Global Forecast to 2022, published by MarketsandMarkets™, the market is expected to reach USD 2,047.9 Million by 2022 from an estimated USD 715.7 Million in 2017, at a CAGR of 23.4%. The key factors driving the growth of this market include increasing prevalence of cancer, increasing preference for noninvasive procedures, initiatives undertaken by government and global health organizations, technological advancement to augment market revenues, rising emphasis on personalized medicine, and availability of funding for liquid biopsy R&D. Browse 133 Market Data Tables and 44 Figures spread through 204 Pages and in-depth TOC on "Liquid Biopsy Market" Download PDF Brochure: https://www.marketsa

Digital PCR Market – Strategy Adopted By Leading Players - Industry Report 2024

According to research report the digital PCR market is projected to reach USD 6.3 billion by 2024 from USD 4.1 billion in 2019, at a CAGR of 8.8% from 2019 to 2024. The rising incidences of infectious diseases (such as HIV, tuberculosis, and malaria) and genetic disorders; continuous technological advancements in PCR technologies and the commercialization of lab-on-chip devices and microfluidics-based portable instruments; increasing investments, funds, and grants for genomic research; increasing use of biomarker profiling for disease diagnostics; and the successful completion of the Human Genome Project are expected to augment the growth of the global Digital PCR Market over the forecast period. On the other hand, the high instrument costs—especially that of dPCR—and the technical limitations of PCR are expected to limit market growth to a certain extent. Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174151204 The major players operating

Laboratory Informatics Market Worth $3.8 billion by 2024

According to the new market research report ' Laboratory Informatics Market by Type of Solution (LIMS, ELN, ECM, SDMS), Component (Software, Service), Deployment, Industry (Pharmaceutical, Biotechnology, Chemical, Agriculture, Petrochemical, oil & gas) - Global Forecasts to 2024', published by MarketsandMarkets™, the global Laboratory Informatics Market is estimated to reach USD 3.8 billion by 2024 from USD 2.6 billion in 2019, at a CAGR of 7.5% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=203037633 The increasing need for laboratory automation; the development of integrated lab informatics solutions; the need to comply with regulatory requirements; and the growing demand in biobanks/biorepositories, academic research institutes, and CROs are the major factors driving the growth of the Laboratory Informatics Market. On the other hand, lack of integration standards and high maintenance and services co

In Vitro Toxicity Testing Market is expected to reach USD 14.9 billion by 2025

According to the new market research report In Vitro Toxicity Testing Market is expected to reach USD 14.9 billion by 2025 from an estimated USD 9.1 billion in 2020, at a CAGR of 10.3%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=209577065 Due to covid-19 outbreak, there has been a significant increase in Covid-19 testing and drug research. The research in this area is being further undertaken to understand the dynamics of the infection better, which is expected to propel the in vitro toxicology research field further. On the other hand, we are estimating that the major share of diagnostic assays and molecular testing of Covid-19, along with personalized medicine will grow at a stable pace in the next five years. There is a huge increase of manufacturers that have taken key steps to increase patient access to coronavirus diagnostic testing, vaccine and drug development in laboratories, hospitals, and other testing sites across the country

In Vitro Toxicology Testing Market worth $14.9 billion by 2025

According to the new market research report In Vitro Toxicity Testing Market by Product (Assay (Western Blot, Tissue Culture),Equipment, Assay Reagent, Software), Toxicity Endpoints (ADME, Skin Irritation, Corrosion),Industry (Pharmaceutical, Cosmetics)-COVID-19 Impact - Global Forecast to 2025, published by MarketsandMarkets™, the In Vitro Toxicology Testing Market is expected to reach USD 14.9 billion by 2025 from an estimated USD 9.1 billion in 2020, at a CAGR of 10.3%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=209577065 The major factors driving the growth of this market are the opposition to animal testing, technological advancements, and increasing R&D expenditure to detect toxicity at an early stage during drug development are the primary growth drivers for this market. Due to covid-19 outbreak, there has been a significant increase in Covid-19 testing and drug research. The research in this area is being further under